CD47

CD47 분자 정보

영어 이름Cluster of differentiation 47시판 약물 수0
임상 약물 수48표적 별명MER6,CD47,Leukocyte surface antigen CD47,CD47 Molecule,Antigenic Surface Determinant Protein OA3,CD47 Antigen (Rh-Related Antigen, Integrin-Associated Signal Transducer),Antigen Identified By Monoclonal Antibody 1D8,Integrin Associated Protein,Rh-Related Antigen,CD47 Glycoprotein,IAP,Integrin-Associated Signal Transducer,Protein MER6,OA3,CD47 Antigen,Integrin-Associated Protein
최고 연구 개발 단계Phase 3 Clinical
영어 이름Cluster of differentiation 47
표적 별명MER6,CD47,Leukocyte surface antigen CD47,CD47 Molecule,Antigenic Surface Determinant Protein OA3,CD47 Antigen (Rh-Related Antigen, Integrin-Associated Signal Transducer),Antigen Identified By Monoclonal Antibody 1D8,Integrin Associated Protein,Rh-Related Antigen,CD47 Glycoprotein,IAP,Integrin-Associated Signal Transducer,Protein MER6,OA3,CD47 Antigen,Integrin-Associated Protein
시판 약물 수0
임상 약물 수48
최고 연구 개발 단계Phase 3 Clinical

CD47 제품 목록

  • 속성

    Protein (21)Beads (1)Kits (2)

  • 제품 라이브러리

    온라인 (24)

  • Human (12)Mouse (5)Cynomolgus / Rhesus macaque (4)Rat (1)Rabbit (1)Canine (1)

  • 태그

    Fc Tag (5)His Tag (6)Fc Tag & Avi Tag (3)Mouse IgG Fc Tag (2)His Tag & Avi Tag (4)Mouse IgG Fc Tag & Avi Tag (1)- (3)

  • 마커

    Unconjugated (13)Biotin-labeled (7)FITC Labeled (1)- (3)

CD47분자 배경

Leukocyte surface antigen CD47 is also known as Antigenic surface determinant protein OA3, Integrin-associated protein (IAP) and Protein MER6. CD47 contains 1 Ig-like V-type (immunoglobulin-like) domain. CD47 is very broadly distributed on normal adult tissues. CD47 has a role in both cell adhesion by acting as an adhesion receptor for THBS1 on platelets, and in the modulation of integrins and plays an important role in memory formation and synaptic plasticity in the hippocampus by similarity. CD47 is the receptor for SIRPA, binding to which prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells. CD47 Interaction with SIRPG mediates cell-cell adhesion, enhances superantigen-dependent T-cell-mediated proliferation and costimulates T-cell activation.

CD47분자 별명

CD47,MER6,IAP,OA3

라이선싱 협력

프로젝트 이름약물 유형치료 영역적응증단계권리 지역
CD47 Monoclonal AntibodyMonospecific antibodyOncology/CancerAdvanced solid tumor,Advanced hematological tumorINDGlobal

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
IMC-002(Immuneoncia)IMC-002; 3D-197; 3D197Phase 3 ClinicalImmuneoncia Therapeutics IncHematologic Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neuromyelitis Optica; Solid tumours; Stomach Neoplasms
상세
TimdarpaceptIMM01; IMM 01; IMC-001Phase 3 ClinicalAtherosclerosis; Cardiovascular Diseases; Hematologic Neoplasms; Hodgkin Disease; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Leukemia, Promyelocytic, Acute; Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms; Solid tumours
상세
EvorpaceptALX148; ALX-148Phase 3 ClinicalAlexo TherapeuticsCarcinoma, Transitional Cell; Composite Lymphoma; Esophageal Neoplasms; Head and Neck Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Metastatic breast cancer; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasm Metastasis; Neoplasms; Oropharyngeal Neoplasms; Plasmablastic Lymphoma; Primary mediastinal B cell lymphoma; Richter's Syndrome; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Urinary Bladder Neoplasms
상세
Amulirafusp alfaIMC-002; IMM-0306Phase 3 ClinicalGlomerulonephritis, Membranous; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Nephrosis; Neuromyelitis Optica
상세
LigufalimabAK-117Phase 3 ClinicalBiliary Tract Neoplasms; Carcinoma, Hepatocellular; Esophageal Neoplasms; Hodgkin Disease; Leukemia, Myeloid, Acute; Lymphoma; Myelodysplastic Syndromes; Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms
상세
Magrolimab5F9; Hu5F9-G4; ONO-7913; GS-4721Phase 2 ClinicalStanford UniversityBrain Neoplasms; Carcinoma, Transitional Cell; Colorectal Neoplasms; Hodgkin Disease; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Multiple Myeloma; Mycosis Fungoides; Myelodysplastic Syndromes; Neuroblastoma; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Sezary Syndrome; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
상세
AO-176AO-176; Ti-104; Ti-108; Ti-176Phase 2 ClinicalArch Oncology IncMultiple Myeloma; Solid tumours
상세
OntorpaceptTTI-621Phase 2 ClinicalThe Hospital For Sick Children, Trillium Therapeutics Inc, University Health Network (Uhn)Breast Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Hematologic Neoplasms; Leiomyosarcoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Melanoma; Multiple Myeloma; Mycosis Fungoides; Papillomavirus Infections; Primary mediastinal B cell lymphoma; Sarcoma; Skin Neoplasms; Solid tumours
상세
AUR-103AUR-103Phase 2 ClinicalAurigeneGastroesophageal Junction Neoplasms; Leukemia; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Solid tumours; Stomach Neoplasms
상세
MaplirpaceptTTI-622; PF-07901801Phase 2 ClinicalTrillium Therapeutics IncCarcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Hematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Multiple Myeloma; Ovarian Neoplasms; Peritoneal Neoplasms; Primary mediastinal B cell lymphoma; Skin Neoplasms
상세
DSP-107KAHR-107; DSP-107Phase 2 ClinicalKahr MedicalCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Solid tumours
상세
BRB-002BRB-002Phase 2 ClinicalBitterroot Bio IncAtherosclerosis; Cardiovascular Diseases; Vasculitis
상세
HCB-101HCB-101Phase 2 ClinicalHanchorBio IncCarcinoma, Renal Cell; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms
상세
LB-101 (Centessa Pharmaceuticals)LB-101 (Centessa Pharmaceuticals); LB-101 Tetravalent PD-L1xCD47 LockBody bispecific monoclonal antibodyPhase 2 ClinicalCentessa Pharmaceuticals PlcSolid tumours
상세
SpevatamigPT-886; PT886Phase 2 ClinicalPhanes Therapeutics IncBiliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
상세
PeluntamigPT-217Phase 2 ClinicalPhanes Therapeutics IncCarcinoma, Neuroendocrine; Neuroendocrine Carcinoma of Lung; Prostatic Neoplasms; Small Cell Lung Carcinoma; Solid tumours
상세
BCD-106BCD-106Phase 2 ClinicalBIOCAD JSCSolid tumours
상세
BAT-7104BAT-7104Phase 2 ClinicalBio-Thera Solutions LtdNeoplasms; Solid tumours
상세
IMM-2902IMM-2902Phase 2 ClinicalBreast Neoplasms; Cholangiocarcinoma; Lung Neoplasms; Solid tumours; Stomach Neoplasms
상세
6MW-32116MW3211; 6MW-3211Phase 2 ClinicalMabwell (Shanghai) Bioscience Co LtdCarcinoma, Renal Cell; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Myelodysplastic Syndromes; Neoplasms
상세
JMT-601JMT-601Phase 2 ClinicalShanghai Jmt-Bio IncGlomerulonephritis, Membranous; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nephrosis
상세
LemzoparlimabABBV-IMAB-TJC4; TJ-1133; TJ-011133; TJC-4Phase 2 ClinicalAbbvie Inc, I-Mab Biopharma Co LtdHematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Solid tumours
상세
Anti-CD47 monoclonal antibody (Biocad)Phase 1 ClinicalBIOCAD JSCNeoplasms
상세
Recombinant humanized monoclonal antibody MIL95 (Mabworks/Connaught Biomedical Technology)MIL-95; CM-312Phase 1 ClinicalBeijing Mabworks Biotech Co LtdLeukemia, Myeloid, Acute; Lymphoma; Neoplasms; Solid tumours
상세
ZeripatamigTG-1801; NI-1701Phase 1 ClinicalNovimmune SaLeukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Richter's Syndrome
상세
SL-172154SL-172154; SIRPα -Fc-CD40LPhase 1 ClinicalShattuck Labs IncCarcinoma, Ovarian Epithelial; Carcinoma, Squamous Cell; Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Ovarian Neoplasms; Peritoneal Neoplasms; Squamous Cell Carcinoma of Head and Neck
상세
SimridarlimabIBI-322; IBI322Phase 1 ClinicalBone Marrow Neoplasms; Hematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, T-Cell; Neoplasms; Solid tumours
상세
anti-CD47 mAb (Hangzhou Sumgen Biotechnology/Zhongsheng Sumgen Biotechnology)SG-404 (Hangzhou Sumgen)Phase 1 ClinicalZhongsheng Shangjian Biological Medicine (Hangzhou) Co LtdHematologic Neoplasms; Solid tumours
상세
anti-CD47/CD20 bispecific antibody (Bristol-Myers Squibb Co)Phase 1 ClinicalBristol-Myers Squibb CompanyHematologic Neoplasms; Lymphoma, Non-Hodgkin
상세
ZL-1201ZL-1201Phase 1 ClinicalZai Lab (Shanghai) Co LtdHematologic Neoplasms; Neoplasms; Solid tumours
상세
HMPL-A83HMPL-A-83; HMPL-A83Phase 1 ClinicalHematologic Neoplasms; Neoplasms; Solid tumours
상세
NI-1801NI-1801Phase 1 ClinicalLight Chain Bioscience LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Solid tumours; Triple Negative Breast Neoplasms
상세
IMM-0306SIMM0306S; IMM-0306SPhase 1 ClinicalLupus Erythematosus, Systemic
상세
AK-132AK132; AK-132Phase 1 ClinicalNeoplasms; Solid tumours
상세
D3L-001D3L-001Phase 1 ClinicalD3 Bio (Wuxi) Co LtdNeoplasms; Solid tumours
상세
FP-002 (Fapon Biopharma)FP-002Phase 1 ClinicalGuangdong Fapon Biopharma IncNeoplasms; Solid tumours
상세
BC-007 (Dragonboat Biopharmaceutical)BC-007Phase 1 ClinicalDragonboat BiopharmaceuticalNeoplasms; Solid tumours
상세
SG-1906SG-1906; SG1906Phase 1 ClinicalHangzhou Shangjian Biotechnology Co LtdNeoplasms; Solid tumours
상세
LD-002LD-002Phase 1 ClinicalZhejiang Blue Shield Pharmaceutical Co LtdHematologic Neoplasms; Lymphoma, Non-Hodgkin; Solid tumours
상세
SHS-009SHS-009; SH009; SH-009Phase 1 ClinicalNanjing Sanhome Pharmaceutical Co Ltd Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Liver Neoplasms; Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms
상세
Monoclonal Antibody (Mab) sB24MPhase 1 ClinicalSwiss Biopharma Med GmbHPyoderma; Pyoderma Gangrenosum
상세
IMM-2520IMM-2520Phase 1 ClinicalBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
상세
STI-6643STI-6643Phase 1 ClinicalSorrento Therapeutics IncNeoplasms; Solid tumours
상세
PF-07257876Phase 1 ClinicalPfizer IncCarcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck
상세
TQB-2928TQB-2928Phase 1 ClinicalJiangsu Chia Tai-Tianqing Pharmaceutical Co LtdCarcinoma, Non-Small-Cell Lung; Hematologic Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms; Osteosarcoma; Solid tumours
상세
IMM2505IMM2505; IMM-2505Phase 1 ClinicalSunHo (China) BioPharmaceutical Co LtdSolid tumours
상세
SG404SG-404; SG404Phase 1 ClinicalHangzhou Shangjian Biotechnology Co LtdNeoplasms
상세
Kintuzumab(GenSci)Phase 1 ClinicalChangchun GeneScience Pharmaceuticals Co LtdHematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Solid tumours
상세

제품 리뷰

  • L***z2026-02-12
    0사람들이 좋아합니다
    I have been using the protein for ELISA assays, andit has met our experimental requirements without any issues. Low doses are sufficient for coating, which makes the assays cost-effective while still providing strong and consistent signal. The shipping was fast and the product arrived in excellent condition.
  • A***r2023-01-31
    0사람들이 좋아합니다
    A new ELISA binding was set up with this new recombinant protein. Among the various suppliers evaluated, the one from Acro Biosystem has been selected. Low doses are needed for coating in comparison to other providers. In addition, data quality was confirmed on repeatition runs. Finally, product delivery was quick and the interaction with our local business development manager is highly satisfaying.
  • R***e2022-09-10
    0사람들이 좋아합니다
    Heard about ACRO from word of mouth from coworkers here at PPD and decided to browse the internet . My team purchased this product for some ELISA testing at the lab. We have been satisfied with the results so far. Great repeatability, sustainability, and specificity as compared to other vendors! It’s very creditable in my opinion. All and all ACRO definitely has some great quality products that are also more cost-effective compared to different vendors like MSD!
더 불러오기
  • 분자 정보
  • 제품 목록
  • 제품 리뷰
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호